Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
McGuff Pharmaceuticals
McGuff Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Ascor
Ascorbic acid
2017-10-02
2024-2033
Common cold
,
Constipation
,
Methemoglobinemia
,
Penetrating wounds
,
Tyrosinemias
,
Scurvy
,
Hypercholesterolemia
,
Hypophosphatemia
,
Hypertriglyceridemia
,
Peripheral vascular diseases
,
Dermatitis
,
Alcoholic neuropathy
,
Seizures
,
Vitamin a deficiency
,
Hypoparathyroidism
,
Inborn errors metabolism
,
Photosensitivity disorders
,
Thiamine deficiency
,
Folic acid deficiency
,
Rickets
,
Vitamin b 6 deficiency
,
Megaloblastic anemia
,
Vitamin b deficiency
,
Xerophthalmia
,
Wernicke encephalopathy
,
Beriberi
,
Night blindness
,
Riboflavin deficiency
,
Pellagra
,
Chronic kidney failure
,
Cardiovascular diseases
,
Psoriasis
,
Lung neoplasms
,
Crohn disease
,
Skin neoplasms
,
Familial hypophosphatemic rickets
,
Osteoporosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ascorbic acid
keratoconjunctivitis sicca
,
healthy volunteers/patients
,
retinal diseases
,
diabetic retinopathy
,
dry eye syndromes
,
pigmentation
Albumin
renal cell carcinoma
,
colorectal neoplasms
,
non-small-cell lung carcinoma
,
melanoma
,
lymphoma
,
neoplasms
,
prostatic neoplasms
,
carcinoma
,
ovarian neoplasms
,
pancreatic neoplasms
,
aggression
,
inflammatory breast neoplasms
,
lung neoplasms
,
sarcoma
,
ovarian epithelial carcinoma
,
breast neoplasms
,
type 2 diabetes mellitus
,
diabetes mellitus
,
hyperglycemia
Aglatimagene besadenovec
lymphoma
,
triple negative breast neoplasms
,
pharmacokinetics
,
healthy volunteers/patients
,
pharmacological phenomena
,
neoplasms
,
breast neoplasms
,
adenocarcinoma
,
neoplasm metastasis
,
carcinoma
,
ovarian neoplasms
,
non-small-cell lung carcinoma
,
pancreatic neoplasms
,
colorectal neoplasms
,
lung neoplasms
,
uterine cervical neoplasms
,
endometrial neoplasms
,
stomach neoplasms
,
urinary bladder neoplasms
,
small cell lung carcinoma
,
biliary tract neoplasms
,
bone neoplasms
,
bone diseases
,
hereditary breast and ovarian cancer syndrome
,
aggression
,
head and neck neoplasms
,
dna repair-deficiency disorders
,
sarcoma
,
ovarian epithelial carcinoma
,
recurrence
,
hypersensitivity
,
gynecomastia
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
heart failure
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
osteoporosis
,
obesity
,
disease susceptibility
,
hepatocellular carcinoma
,
liver neoplasms
Sodium ascorbate
bacterial infections
,
respiratory tract infections
,
infections
,
iron-deficiency anemia
,
hematopoiesis
,
iron deficiencies
,
human influenza
,
common cold
,
inflammation
,
vascular stiffness
Retinol
neoplasms
,
breast neoplasms
,
carcinoma
,
triple negative breast neoplasms
,
fallopian tube neoplasms
,
squamous cell carcinoma of head and neck
,
small cell lung carcinoma
,
squamous cell carcinoma
,
esophageal squamous cell carcinoma
,
pharyngeal neoplasms
,
peritoneal neoplasms
,
healthy volunteers/patients
,
head and neck neoplasms
,
atrial fibrillation
,
stomach neoplasms
,
ovarian neoplasms
,
pancreatic ductal carcinoma
,
biliary tract neoplasms
,
non-small-cell lung carcinoma
,
esophageal neoplasms
,
ocular hypertension
,
castration-resistant prostatic neoplasms
,
endometrial neoplasms
,
adenocarcinoma
,
lung neoplasms
,
pneumonia
,
lung injury
,
colorectal neoplasms
,
diabetes mellitus
,
type 1 diabetes mellitus
,
schizophrenia
,
psychotic disorders
,
mental disorders
,
metabolic diseases
,
calcium metabolism disorders
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use